Trade name: Rinofluimucil®.

Dosage form:>nasal spray

Composition

100 ml of solution contains

Active ingredients: acetylcysteine ​​– 1.0 g, tuaminoheptane sulfate – 0.5 g;

Excipients: benzalkonium chloride 0.01 g, hypromellose 0.75 g, disodium edetate 0.02 g, sodium dihydrogen phosphate 0.3 g, sodium hydrogen phosphate dodecahydrate 0.3 g, dithiothreitol 0 .1 g, sorbitol 70% 2.0 g, mint flavor 0.0188 g, ethanol 96% 0.31 g, sodium hydroxide 0.36 g, purified water up to 100 ml.

Description

Almost colorless transparent liquid with a characteristic minty, slightly sulfurous odor.

Pharmacotherapeutic group: anticongestive agent.

Pharmacological properties

Pharmacodynamics.

The mucolytic and vasoconstrictor effect of Rinofluimucil® is a reflection of the pharmacological properties of the active substances included in its composition

Active substances (per 100 ml):

• Acetylcysteine – 1.0 g (mucolytic agent)
• Tuaminoheptane sulfate – 0.5 g (vasoconstrictor)

Excipients:

• Benzalkonium chloride, hypromellose, disodium edetate
• Sodium dihydrogen phosphate, sodium hydrogen phosphate dodecahydrate
• Dithiothreitol, sorbitol 70%, mint flavouring, ethanol 96%, sodium hydroxide, purified water

Administer as a nasal spray by directing the nozzle into each nostril. The usual dose for adults is 2–3 sprays per nostril, 3–4 times daily. Do not exceed 7 days of continuous use without medical advice. Consult a physician before use, especially in children, pregnant women, or patients with cardiovascular conditions.

fawsfgsag